Supplementary Figure 11 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities Via NAD+ Depletion | AMiner
Supplementary Figure 11 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities Via NAD+ Depletion
Katelyn J. Noronha,Karlie N. Lucas,Sateja Paradkar,Joseph Edmonds,Sam Friedman,Matthew A. Murray,Samantha Liu,Dipti P. Sajed,Chana Sachs,Josh Spurrier,Mitch Raponi,Jiayu Liang,Hao Zeng,Ranjini K. Sundaram,Brian Shuch,Juan C. Vasquez,Ranjit S. Bindra
crossref（2026）
被引用0|浏览0
摘要
Combination of PARPi and NAMPTi lead to unresolved double stranded breaks NAPRT silenced models.
原文链接
分享
引用
